Purpose-Driven and Future-Focused
Our mission to improve patient health and safety guides everything we do—and shapes our commitment to sustainability. This deep sense of responsibility is reflected in how we operate as a business, with a focus on People-Centric Culture, Ethical Leadership, and Climate Stewardship.
Our SBTi-validated emissions reduction targets and EcoVadis Commitment badge reflect continued progress, and as part of our journey, have detailed action plans to continuously improve our rating.
People-Centric Culture
We foster a culture of respect, inclusion, and opportunity to enable employee well-being, professional growth, and a culture of belonging.
- Dedicated DEI program and leadership
- Risk inventory assessments
- Volunteer and flexible time off
- Wellness benefits, annual programming, and challenges
- Employee Resource Groups and clubs
- Feedback and upward mobility
- Charity match programs
- Talent acquisition and retention
- Mentorship programs
- Training and continuous education opportunities
- And more!
Ethical Leadership
We uphold integrity, transparency, and accountability in all aspects of our business, ensuring responsible decision-making, data privacy, and compliance with global standards.
- Advanced Data Security and Privacy Programs
- Compliance with labor laws within each operating region
- Quarterly Board Reporting on Sustainability Program
- Transparent and accessible leadership through Town Halls
Climate Stewardship
We are focused on minimizing our environmental footprint through science-based climate action, responsible resource management, and continuous improvement in sustainability practices.
- Remote workforce commitment
- Employee Education & Green Team
- EcoVadis Commitment Badge
- Approved near- and long-term science-based emissions reduction targets with the Science Based Targets initiative (SBTi)
- Annual energy and carbon reporting
Our near-term and long-term emissions reduction targets have been independently validated by SBTi Services in accordance with the SBTi Near-Term and Net-Zero Criteria.
Driving Progress Through Collaboration
Our Sustainability Program is guided by a dedicated Steering Committee made up of executive and senior leaders from across our global operations. This cross-functional group is responsible for driving progress across all pillars of our sustainability strategy. The committee ensures accountability, approves new initiatives, and proactively plans for evolving regional requirements and standards to maintain meaningful, forward-looking impact.
News & Insights
August 3, 2026
Efficiency and Compliance: Mastering Legal Case Processing in Pharmacovigilance
Explore strategies for efficient legal case processing in pharmacovigilance, ensuring compliance and enhancing patient safety amidst rising litigation challenges.
July 29, 2026
EMA PRIME Eligibility: Accelerating Access to the European Union Market
Learn what EMA PRIME eligibility is, who qualifies, & how it accelerates innovative medicines through early scientific advice, regulatory support, & optimized EU development pathways.
July 27, 2026
From Feasibility to First Patient In: Streamlining Study Start‑Up with Confidenc...
Discover how ProPharma streamlines clinical trial study start-up, ensuring predictable activation and reducing risks from feasibility to first patient in.cl
.png?width=320&height=185&name=2%20-%20Clinical%20Research%20Solutions%20%20(650%20x%20425%20px).png)
.png?width=320&height=185&name=6%20-%20Medical%20Information%20%20(650%20x%20425%20px).png)
.png?width=320&height=185&name=4%20-%20Quality%20%26%20Compliance%20(650%20x%20425%20px).png)
News & Insights
July 8, 2026
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...
ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.
June 18, 2026
ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...
ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.
May 27, 2026
ProPharma Appoints Adrian Pencak as Chief Commercial Officer
ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.
